PPAC and Its Possible Effects on Medical Expense Tort Damages
In last month's issue, we began a discussion of how the mandatory health insurance requirement of the Patient Protection and Affordable Care Act of 2010 (PPAC) could work to reduce the amount of tort damages recoverable for medical expenses. We continue herein.
Features
Hospital-Acquired Infections Are on the Rise
On Oct. 16, 2007, the Centers for Disease Control and Prevention (CDC), in Atlanta, issued a press release stating that, for the first time, Methicillin-resistant Staphylococcus auereus (MRSA) was killing more people than AIDS.
Medicare Set-Asides in Med-Mal and Personal Injury Litigation
An issue that arises with increasing frequency is whether, and to what extent, funds should be allocated from a settlement to provide for future medical costs that Medicare would otherwise be required to pay.
mHealth: Boon or Bane?
Until issues of privacy and security can be addressed, it would be best for physicians to limit their use of mHealth to nonconfidential communications. The risks currently outweigh the benefits.
Features
Federal Health Care Law May Reduce or Eliminate Future Medical Expense Tort Damages
The mandatory health insurance requirement of the Patient Protection and Affordable Care Act of 2010 (PPAC) should significantly reduce the amount of tort damages recoverable for medical expenses. Here's how.
Top Tips: Reducing the Risks and Managing the Consequences of Radiation Injury
Radiology professionals and firms that manufacture radiology equipment must anticipate the possibilities of tort claims, and plan ahead to limit the damage they can cause.
Features
<B><I>BREAKING NEWS:</b></i> <b>Eleventh Circuit Strikes Down Individual Mandate</b>
The Eleventh U.S. Circuit Court of Appeals on Aug. 12 gave a partial victory to challengers of the 2010 federal health care overhaul, finding unconstitutional the part of the law that requires individuals to obtain health insurance but upholding the rest of the statute.
Need Help?
- Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
- Need other assistance? email Customer Service or call 1-877-256-2472.
MOST POPULAR STORIES
- Protecting Innovation in the Cyber World from Patent TrollsWith trillions of dollars to keep watch over, the last thing we need is the distraction of costly litigation brought on by patent assertion entities (PAEs or "patent trolls"), companies that don't make any products but instead seek royalties by asserting their patents against those who do make products.Read More ›
- Meet the Lawyer Working on Inclusion Rider LanguageAt the Oscars in March, Best Actress winner Frances McDormand made “inclusion rider” go viral. But Kalpana Kotagal, a partner at Cohen Milstein Sellers & Toll had already worked for months to write the language for such provisions. Kotagal was developing legal language for contract provisions that Hollywood's elite could use to require studios and other partners to employ diverse workers on set.Read More ›
- From the PTO to the FDA: What to Consider When Branding Clinical TrialsThe legal implications of branding generally arise initially for companies during the process of selecting a company name and any initial product or service names. For drug development companies, however, careful consideration should also be paid to the implications of branding a clinical trial.Read More ›
- Use of Deferred Prosecution Agreements In White Collar InvestigationsThis article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.Read More ›